Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in United Arab Emirates

The Polio Vaccine Third Dose (Pol3) immunization coverage in the United Arab Emirates has shown some fluctuations over the past decade. From 2013 to 2016, the coverage rate was relatively stable around 98-99%. A notable dip occurred in 2017 and again in 2019, with a more significant drop to 80% in 2020, likely impacted by the COVID-19 pandemic. However, the immunization rate has been recovering since, standing at 96% in 2023.

Looking at the year-on-year variations, there was a peak decline of 15.79% in 2020, followed by an 11.25% recovery in 2021. The overall Compound Annual Growth Rate (CAGR) over the past five years has been -0.61%, indicating a slight downward trend. Moving forward, the forecast suggests a modest annual growth rate of 0.21% through 2028.

Future trends to watch for include:

  • Continued recovery of immunization rates post-pandemic.
  • Government and public health interventions aiming to sustain and improve coverage.
  • Potential impacts of global healthcare initiatives and local policy changes.

Latest reports

 US Vaccine Market Report- Q1 2025

US Vaccine Market Report- Q1 2025

The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...

 China Vaccine Market Report- Q1 2025

China Vaccine Market Report- Q1 2025

The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...

 Japan Vaccine Market Report- Q4 2024

Japan Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...

 Germany Vaccine Market Report- Q4 2024

Germany Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...

 India Vaccine Market Report- Q4 2024

India Vaccine Market Report- Q4 2024

The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...

 UK Vaccine Market Report- Q4 2024

UK Vaccine Market Report- Q4 2024

The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...

 France Vaccine Market Report- Q4 2024

France Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...

 Canada Vaccine Market Report- Q4 2024

Canada Vaccine Market Report- Q4 2024

The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...

 Brazil Vaccine Market Report- Q4 2024

Brazil Vaccine Market Report- Q4 2024

The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...

 Italy Vaccine Market Report- Q4 2024

Italy Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...

Top Countries about mRNA Vaccine